MedTrace Logo

Venous Insufficiency and Neuromuscular Stimulation

NCT02137499 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-10-25

Study results available
· View outcomes & findings →

Summary

The investigators will be evaluating the immediate and longer term effect of treatment with a medical device on the symptoms of chronic venous disease.

Conditions

  • Chronic Venous Disease
  • Venous Insufficiency
  • Deep Venous Obstruction

Interventions

DEVICE

geko device

Small transcutaneous electrical stimulator. Manufactured in UK by Firstkind UK Ltd, and licensed for use in humans

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Alun Davies · Imperial College London

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02137499 on ClinicalTrials.gov